Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
The Bing Center for Waldenström's Macroglobulinemia provides care and new therapies through clinical trials to patients with Waldenström's macroglobulinemia and related Immunoglobulin M (IgM) disorders.
The Bing Center for Waldenström's Macroglobulinemia provides a comprehensive range of services for patients with Waldenström's macroglobulinemia, including:
The Bing Center for Waldenström's Macroglobulinemia encompasses a large, international team of laboratory-based and clinical investigators who are striving to find more effective therapies for Waldenström's macroglobulinemia and, someday, a cure.
Steven P. Treon, MD, PhD, director, Bing Center for Waldenström's Macroglobulinemia
Treon's main research interests focus on understanding the genetic basis and pathogenesis of Waldenström's and the development of novel therapeutics. He serves on the editorial boards of Journal of Clinical Oncology, Blood, Clinical Cancer Research, and The Lancet. He has been honored with several research and academic awards, including the Robert A. Kyle Award for Waldenström's.
Jorge J. Castillo, MD
Castillo's research studies the various risk factors that could be associated with an increased risk of developing hematologic malignancies. He has run a series of investigator-initiated prospective clinical trials using non-chemotherapeutic regimens, and has developed several multi-institutional efforts to study Waldenström's macroglobulinemia and other lymphomas. His work has been published in Journal of Clinical Oncology, Blood, Leukemia, Cancer, British Journal of Haematology, and Leukemia and Lymphoma.
Toni Dubeau, NP
Dubeau joined the Waldenström's team to foster long-term relationships with patients in this setting. Before her work at Dana-Farber, she spent 13 years at Brigham and Women's Hospital caring for patients in a variety of settings, including bone marrow transplant and cardiology.
Patricia Severns, NP
Each patient's care combines the finest treatments currently available for Waldenström's macroglobulinemia with innovative new therapies based on research discovered through the collaboration of the center's laboratories and many other scientists from around the world.
The Bing Center for Waldenström's Macroglobulinemia offers patients access to a wide range of clinical research trials. The main goal of clinical research at the Bing Center for Waldenström's Macroglobulinemia is to swiftly and efficiently take discoveries made in the laboratory to the clinic where they can benefit the health and well-being of the patient.
This include studies aimed at improving the outcomes of patients undergoing biological therapies using agents in trials such as Rituxan and bortezomib that attempt to kill Waldenström's macroglobulinemia tumor cells directly. The center also has clinical research trials evaluating supportive therapies like statins and phosphodiesterase inhibitors to help understand the mechanics of the disease.
Waldenström's Macroglobulinemia: 617-632-3823 or 617-632-5138, or use this online form to make an appointment.
You may schedule your first appointment for as soon as the next day. After scheduling, one of our nurses will call you to answer your questions and help you prepare for the appointment.
Contact your doctor directly, or for general inquiries, call the Hematologic Malignancies program at 617-632-6140.
Hematologic Malignancies DivisionDana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215